Adlib Software has appointed Kristen Sauter as President and General Manager of Life Sciences, aiming to enhance its vertical AI strategy amid increasing challenges in the industry.
Sauter, who brings over two decades of experience in regulatory data and AI solutions within the pharma and biopharma sectors, previously held significant roles at Deloitte and Takeda. Her appointment signals Adlib's commitment to addressing the complexities of AI implementation in life sciences, particularly in clinical trials, regulatory submissions, and manufacturing processes. As organizations strive to integrate AI while ensuring compliance with regulatory bodies like the FDA and EMA, Sauter’s expertise will be vital in navigating these challenges.
The life sciences sector is witnessing a surge in AI investments, yet many organizations struggle to operationalize these technologies effectively. The primary obstacle lies not in the AI models themselves but in the quality of the underlying data and documents, which are often poorly formatted and difficult to audit. Reports indicate that a staggering 60-80% of documents used in AI models are not ready for AI applications, leading to serious compliance issues and operational inefficiencies.
As the industry grapples with these challenges, Adlib’s strategic focus on enhancing AI defensibility could prove crucial. By investing in leadership that understands both regulatory demands and AI capabilities, the company aims to mitigate risks and support life sciences organizations in successfully leveraging AI technologies.